Atypical antipsychotics in the treatment of schizophrenia: Systematic overview and meta-regression analysis

British Medical Journal

Volumn 321, Issue 7273, 2000, Pages 1371-1376

  Geddes, J ^a   Freemantle, N ^b   Harrison, P ^a   Bebbington, P ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; CHLORPROMAZINE; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SERTINDOLE;

ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SCHIZOPHRENIA; SCORING SYSTEM;

EID: 0034598111     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.321.7273.1371     Document Type: Article

References (21)

1. Treatment of schizophrenia
2. Antipsychotic drugs: Is more worse? A meta-analysis of the published randomized control trials
3. Patterns of usual care for schizophrenia: Initial results from the schizophrenia patient outcomes research team (PORT) client survey
4. Clozapine versus typical neuroleptic medication for schizophrenia
5. Olanzapine for schizophrenia
6. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials
7. Quetiapine for schizophrenia
8. Risperidone in the treatment of schizophrenia: A meta-analysis
9. Risperidone versus typical antipsychotic medication for schizophrenia
10. Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
11. Methods of developing guidelines for efficient drug use in primary care: North of England evidence-based guidelines development project
12. The brief psychiatric rating scale
13. The positive and negative syndrome scale for schizophrenia
14. Bayesian approaches to random-effects meta-analysis: A comparative study
15. Meta-analysis in clinical trials
16. Systematic reviews of randomised trials
17. Antipsychotic-induced weight gain: A comprehensive research synthesis
18. Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol
19. Olanzapine and tardive dyskinesia